Did you know?
- As of March 31, 2016, Abaxis, Inc. had
549 full-time employees.
- Peter Koerte is President, Point of Care
Diagnostics at Siemens Healthineers.
- Four HemoCue point-of-care tests are
performed each second worldwide.
-iLine Microsystems earned the 2016 Frost
& Sullivan Enabling Technology Leadership Award.
- With over 80,000 placements in
high-acuity settings worldwide and 35 million test cartridges produced
annually, Abbott Point Of Care’s i-STAT® System has a global impact on bedside
point-of-care testing.
- QuantuMDx Group’s first available test
will take the guess work out of warfarin dosage by identifying at the
point-of-care, subsets of the population who could develop life-threatening
bleeds on the standard dose.
- ChroMedX Corp’s HemoPalm Handheld Blood
Analyzer System is the only handheld blood analysis technology which combines
Blood Gases and Electrolytes with full CO-Oximetry.
- At 60 seconds for a reading, bioLytical
Laboratories’ INSTI® Kit is the fastest HIV diagnostic assay in the world
today.
- Arbor Vita Corporation’s flagship
point-of-care product - the OncoE6™ Cervical Test - has proven to be the most
accurate test available worldwide for detecting cervical cancer.
- On March 7, 2017, Alere Inc. announced
that its Alere™ i RSV test, the first molecular test that can be used at the
point-of-care to detect RSV (respiratory syncytial virus) infection in children
and adults in 13 minutes or less,had been granted CLIA waiver by the FDA.
- As well as developing its own family of
products, Philips Handheld Diagnostics is open to collaborating with other
healthcare companies to exploit the full potential of its Minicare technology.
- For the fiscal year ended March 31, 2016,
Abaxis, Inc. reported revenues from continuing operations of $218.9 million.
- On January 20, 2017 Werfen and its
subsidiary Instrumentation Laboratory (IL) announced the acquisition of Accriva
Diagnostics.
These are just a tiny sample of the 1,000's
of facts to be found in ‘The Top 150 Manufacturers Of Point-Of-Care Instruments
& Tests’.
This unique and comprehensive report
identifies and profiles the 150 leading companieswith a focus on point-of-care
diagnostics. There is no other report on the market that does this.
The companies profiled in this report are
located across the globe from the United States and Europe to India and China.
They are the ones with the experience, know-how and resources that enable them
to develop, manufacture and market innovative products that can compete
effectively in global markets. They range from large companies such as Nova
Biomedical Corporation to smaller niche companies such as BioDirection, Inc..
Profile information for each company in
‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ typically
includes:
- Company Contact Information - Address,
Telephone and Fax Numbers, Email and Website Addresses
- Key Company Decision Makers - From CEO
and Main Board, to Key Senior Managers
- Specialised fields such as Company
Description, POC Specialties, Ownership, Number of Employees and Revenue
Report Target Market:
1) Point-Of-Care Manufacturing Companies
Usage: competitive/financial analysis and
strategic partner/alliance identification.
2) Suppliers
‘The Top 150 Manufacturers Of Point-Of-Care
Instruments & Tests’ is perfect for suppliers of raw materials, technology
and services to identify top potential customers.
3) Distributors
This report is ideal for distributors of
point-of-care instruments and tests to identify the leading manufacturers with
the best products.
4) Industry Associations:
‘The Top 150 Manufacturers Of Point-Of-Care
Instruments & Tests’ is a useful reference tool for in-vitro
diagnosticsindustry associations.
Note: Most people will be aware of some of
the major manufacturers of point-of-care instruments and tests such as EKF
Diagnostics, PTS Diagnostics and SD Biosensor, Inc. but this major new report
looks at all 150 of the top companies - companies like:
- Biosensia Ltd. - Founded in 2009 and
headquartered in Dublin, Ireland, Biosensiais a science focused, venture backed
business established specifically to develop and exploit its novel and
proprietary technology, RapiPlex.RapiPlex is a point-of-care diagnosis system
based on a set of proprietary technologies capable of producing quantitative
and qualitative laboratory quality test results.Itcomprises a disposable assay
cartridge and a small table top instrument, making it possible to transition
complex immunoassays from the centralised reference laboratory to a doctor’s
office or patient’s bedside, facilitating near patient care without
compromising analytical performance.The Company’s aim is to make RapiPlex a
method of choice for testing multiple analytes in a matter of minutes.
Biosensiais interested in exploring product commercialisation under license
agreement. It has already signed two development agreements with external
partners for products for TB triage and for the monitoring of systemic Lupus
and discussions are ongoing in severalother areas including sepsis and
infectious disease panels. The Company is led by Niamh O’Luanaigh, Chief
Operating Officer.
- Sarissa Biomedical Limited - Sarissa
Biomedical’s patented technology delivers a step change in enzymatic biosensor
sensitivity and selectivity to detect and measure biomarkers in finger-prick
blood samples within minutes, using low cost, single use biosensors and handheld
readers. This new generation of biosensors is set to transform emergency
clinical care, creating point-of-care diagnostic solutions not previously
possible. The Company’s first application is stroke and it expects to make a CE
marked product available during 2017. Sarissa Biomedical is working on other
diagnostic applications in several major disease areas such as TBI, heart
attacks and sepsis. The Company was founded in 2002 and is headquartered in
Coventry, United Kingdom. Dr Everard Mascarenhas is Sarissa Biomedical’s Chief
Executive Officer.
- Zenosense, Inc.-Zenosense’s primary
focus, through their joint venture ownership in MIDS Medical Ltd., is the
development of a cost-effective, hand-held, point-of-care, rapid cardiac
diagnostic device, MIDS Cardiac™.MIDS Cardiac™ enables the rapid detection of
very low levels of cardiac markers with a primary focus on troponin I and T.
The device is designed to equal or exceed gold standard laboratory levels of
accuracy, at the point-of-care. It is intended to be used with a minimum of
training by any ER nurse or by paramedics at the scene. The Companybelieves
that MIDS Cardiac™ will revolutionise the diagnosis and management of suspected
Acute Myocardial Infarction (AMI), that it will be in universal demand and that
it will rapidly penetrate a multi-billion dollar market.Zenosense was founded
in 2008, is headquartered in Valencia, Spain and is led by Carlos Gil, Chief
Executive Officer.
Report data field structure is as follows:
- Company Name
- Address
- Telephone
- Fax
- Email
- Website
- Year Established
- Number of Employees
- Key Executives
- Company Description
- Products
- POC Specialties
- Revenue ($U.S. million)
- Location Status
- Ownership
- Stock Exchange/Ticker Symbol
- Parent Company Name
Publisher is one of the world’s leading
companies in life sciences publishing. It has a large portfolio of best-selling
reports spanning diagnostics, pharmaceuticals, biotechnology and medical
devices. It’s customers include most of the world’s major companies in these
sectors e.g. Abbott Laboratories, ACON Laboratories, Alcon, Alere, Allergan,
Aurobindo Pharma, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomerieux, Biomet,
Boditech Med, Boehringer Ingelheim, CareFusion, Covance, Covidien, C.R. Bard,
Edwards Lifesciences, EKF Diagnostics, Fresenius, GE Healthcare, Genzyme,
HemoCue, Intuitive Surgical, Ipsen, Johnson & Johnson, Medtronic, Merit
Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann,
Philips Medical, Qiagen,Quidel, Siemens Healthcare, Smith & Nephew,
Synthes, Teleflex, Teva, Tosoh, Zentiva etc.. Publisher also counts many
multinational financial services, law and management consulting firms such as
Bain & Company, McKinsey & Company and The Boston Consulting Group
among its customers.
Publisher currently has customers in some
forty countries across the globe e.g. Austria, Australia, Belgium, Brazil,
Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary,
India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Malta,
Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia,
Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom,
and the United States.
Publisher' reports help you make informed
decisions about the markets and organisations that affect your business.
- Learn more about your target markets and
target companies
- Top level research on all the major
players in a market
- See which organisations dominate your
major markets
- Get detailed information on particular
organisations
Please visit this link for more details: http://mrr.cm/UWP
Find all Pharma
and Healthcare Reports
at: http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.